Leerink Partners Maintains Market Perform on PROCEPT BioRobotics, Raises Price Target to $22
Benzinga Newsdesk 6 hours ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Mike Kratky maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Market Perform and raises the price target from $20 to $22.
Leerink Partners analyst Mike Kratky maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Market Perform and raises the price target from $20 to $22.